Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

AcuCort

0.60 SEK-2.89 %9/9 17:29
Less than 1K followers

ACUC

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
-2.89 %
-1.95 %
-8.21 %
-11.44 %
+0.67 %
+0.50 %
+47.48 %
-79.10 %
-76.34 %

AcuCort is a pharmaceutical company. The company develops and commercializes pharmaceuticals based on well-established substances with a focus on user-friendliness and ease of administration. The company's leading product is an oral film for the acute treatment of allergic reactions and other conditions with high medical demand. Products are aimed at patients and caregivers globally. AcuCort was founded in 2006 and is headquartered in Lund, Sweden.

Read more
Market cap
141.6M SEK
Turnover
105.77K SEK
Revenue
690K
EBIT %
-3,839.13 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/11
2026

Interim report Q3'26

Press release2026-09-07 15:15

Analyst Group: Analyst Group kommenterar AcuCorts beviljade varumärkesskydd av Zeqmelit® i Ukraina

AcuCort
Regulatory press release2026-09-07 13:35

AcuCort AB: AcuCorts läkemedel Zeqmelit® registrerat som varumärke i Ukraina

AcuCort
Regulatory press release2026-09-07 13:35

AcuCort AB: AcuCort's product Zeqmelit® registered as a trade mark in Ukraine

AcuCort

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-09-03 08:54

Investor Studios: AcuCorts VD har ordet: Zeqmelit® i vetenskapliga tidsskrifter

AcuCort
Regulatory press release2026-09-01 13:45

AcuCort's warrant programme fully subscribed - key personnel to become shareholders in the company

AcuCort
Regulatory press release2026-09-01 13:45

AcuCorts teckningsoptionsprogram fulltecknat - företagets nyckelpersoner blir delägare i bolaget

AcuCort
Press release2026-08-31 13:00

AcuCort AB: AcuCort has published August 2026 newsletter

AcuCort
Press release2026-08-31 13:00

AcuCort AB: AcuCort publicerar nyhetsbrev för augusti 2026

AcuCort
Press release2026-08-31 11:42

Analyst Group: Aktieanalys på AcuCort - Regulatoriska hinder undanröjda inför NDA-ansökan

AcuCort
Regulatory press release2026-08-26 08:20

AcuCort AB: AcuCort study on patient preferences published in peer-reviewed scientific journal

AcuCort
Regulatory press release2026-08-26 08:20

AcuCort AB: AcuCorts studie om patientpreferenser publicerad i vetenskaplig tidskrift

AcuCort
Regulatory press release2026-08-24 08:20

AcuCort AB: AcuCort rekryterar Carl Frisk till Strategic Alliance Manager

AcuCort
Regulatory press release2026-08-24 08:20

AcuCort AB: AcuCort appoints Carl Frisk as Strategic Alliance Manager

AcuCort
Press release2026-08-19 11:40

Analyst Group: Analyst Group kommenterar AcuCorts Q2-rapport

AcuCort
Press release2026-08-19 08:42

Investor Studios: AcuCorts VD Jonas Jönmark presenterar kvartalet live 10.00

AcuCort
Regulatory press release2026-08-19 08:20

AcuCort AB: AcuCort publicerar delårsrapport för andra kvartalet 2026

AcuCort
Press release2026-08-11 17:07

Analyst Group: Analyst Group kommenterar AcuCorts kliniska fas IV-studie som har publicerats i en vetenskaplig tidskrift

AcuCort
Regulatory press release2026-08-11 10:12

AcuCort AB: AcuCorts första fas IV-studie är nu publicerad

AcuCort
Regulatory press release2026-08-11 10:12

AcuCort AB: AcuCort's first Phase IV study is now published

AcuCort
Regulatory press release2026-08-07 09:13

AcuCort AB: AcuCort ändrar datum för offentliggörande av delårsrapport för andra kvartalet 2026

AcuCort